ID   STEA3_MOUSE             Reviewed;         488 AA.
AC   Q8CI59; Q3TKE4; Q80ZF3; Q8C5F0; Q924Z1;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   07-APR-2021, entry version 136.
DE   RecName: Full=Metalloreductase STEAP3;
DE            EC=1.16.1.-;
DE   AltName: Full=Dudulin-2;
DE   AltName: Full=Protein nm1054;
DE   AltName: Full=Six-transmembrane epithelial antigen of prostate 3;
DE   AltName: Full=Tumor suppressor-activated pathway protein 6;
GN   Name=Steap3; Synonyms=Tsap6;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=12606722; DOI=10.1073/pnas.0530298100;
RA   Passer B.J., Nancy-Portebois V., Amzallag N., Prieur S., Cans C.,
RA   Roborel de Climens A., Fiucci G., Bouvard V., Tuynder M., Susini L.,
RA   Morchoisne S., Crible V., Lespagnol A., Dausset J., Oren M., Amson R.,
RA   Telerman A.;
RT   "The p53-inducible TSAP6 gene product regulates apoptosis and the cell
RT   cycle and interacts with Nix and the Myt1 kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:2284-2289(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Serru V., Lamblin D., Lenoir C., Manivet P., Vaubourdolle M.,
RA   Kellermann O., Loric S.;
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=Czech II; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, ENZYME ACTIVITY, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE,
RP   HEME-BINDING, COFACTOR, TISSUE SPECIFICITY, AND MUTAGENESIS OF HIS-316 AND
RP   HIS-409.
RX   PubMed=16227996; DOI=10.1038/ng1658;
RA   Ohgami R.S., Campagna D.R., Greer E.L., Antiochos B., McDonald A., Chen J.,
RA   Sharp J.J., Fujiwara Y., Barker J.E., Fleming M.D.;
RT   "Identification of a ferrireductase required for efficient transferrin-
RT   dependent iron uptake in erythroid cells.";
RL   Nat. Genet. 37:1264-1269(2005).
RN   [6]
RP   FUNCTION.
RX   PubMed=16609065; DOI=10.1182/blood-2006-02-003681;
RA   Ohgami R.S., Campagna D.R., McDonald A., Fleming M.D.;
RT   "The Steap proteins are metalloreductases.";
RL   Blood 108:1388-1394(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND SER-20, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND SER-20, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas, Spleen,
RC   and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Endosomal ferrireductase required for efficient transferrin-
CC       dependent iron uptake in erythroid cells. Participates in erythroid
CC       iron homeostasis by reducing Fe(3+) to Fe(2+). Also mediates reduction
CC       of Cu(2+) to Cu(1+), suggesting that it participates in copper
CC       homeostasis. Uses NADP(+) as acceptor. May play a role downstream of
CC       p53/TP53 to interface apoptosis and cell cycle progression. Indirectly
CC       involved in exosome secretion by facilitating the secretion of proteins
CC       such as TCTP. {ECO:0000269|PubMed:16227996,
CC       ECO:0000269|PubMed:16609065}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:Q687X5};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:Q687X5};
CC   -!- SUBUNIT: Homodimer. Interacts with BNIP3L, MYT1, RHBDL4/RHBDD1 and TCTP
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endosome membrane {ECO:0000269|PubMed:16227996};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:16227996}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8CI59-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8CI59-2; Sequence=VSP_024832;
CC   -!- TISSUE SPECIFICITY: Highly expressed in fetal liver (the site of
CC       midgestational hematopoiesis). {ECO:0000269|PubMed:12606722,
CC       ECO:0000269|PubMed:16227996}.
CC   -!- PTM: Proteolytically cleaved by RHBDL4/RHBDD1. RHBDL4/RHBDD1-induced
CC       cleavage occurs at multiple sites in a glycosylation-independent manner
CC       (By similarity). {ECO:0000250}.
CC   -!- PTM: Glycosylated. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Mice display iron deficiency anemia, due to a
CC       defect in iron release through the transferrin cycle.
CC       {ECO:0000269|PubMed:16227996}.
CC   -!- SIMILARITY: Belongs to the STEAP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK50539.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY214462; AAO38239.1; -; mRNA.
DR   EMBL; AY029586; AAK50539.1; ALT_FRAME; mRNA.
DR   EMBL; AK078769; BAC37383.1; -; mRNA.
DR   EMBL; AK167028; BAE39201.1; -; mRNA.
DR   EMBL; AK171237; BAE42333.1; -; mRNA.
DR   EMBL; BC037435; AAH37435.1; -; mRNA.
DR   CCDS; CCDS48343.1; -. [Q8CI59-1]
DR   RefSeq; NP_001078878.1; NM_001085409.1.
DR   RefSeq; NP_573449.2; NM_133186.3.
DR   SMR; Q8CI59; -.
DR   BioGRID; 212849; 3.
DR   IntAct; Q8CI59; 4.
DR   STRING; 10090.ENSMUSP00000108260; -.
DR   GlyGen; Q8CI59; 1 site.
DR   iPTMnet; Q8CI59; -.
DR   PhosphoSitePlus; Q8CI59; -.
DR   SwissPalm; Q8CI59; -.
DR   jPOST; Q8CI59; -.
DR   PaxDb; Q8CI59; -.
DR   PeptideAtlas; Q8CI59; -.
DR   PRIDE; Q8CI59; -.
DR   ProteomicsDB; 257489; -. [Q8CI59-1]
DR   ProteomicsDB; 257490; -. [Q8CI59-2]
DR   GeneID; 68428; -.
DR   KEGG; mmu:68428; -.
DR   CTD; 55240; -.
DR   MGI; MGI:1915678; Steap3.
DR   eggNOG; ENOG502QRP3; Eukaryota.
DR   InParanoid; Q8CI59; -.
DR   PhylomeDB; Q8CI59; -.
DR   TreeFam; TF332031; -.
DR   Reactome; R-MMU-6803204; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release.
DR   Reactome; R-MMU-917977; Transferrin endocytosis and recycling.
DR   BioGRID-ORCS; 68428; 1 hit in 53 CRISPR screens.
DR   ChiTaRS; Steap3; mouse.
DR   PRO; PR:Q8CI59; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q8CI59; protein.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005768; C:endosome; IDA:MGI.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005771; C:multivesicular body; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0008823; F:cupric reductase activity; IDA:MGI.
DR   GO; GO:0052851; F:ferric-chelate reductase (NADPH) activity; IDA:MGI.
DR   GO; GO:0000293; F:ferric-chelate reductase activity; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0015677; P:copper ion import; IDA:MGI.
DR   GO; GO:1990182; P:exosomal secretion; IMP:MGI.
DR   GO; GO:0033212; P:iron import into cell; IDA:MGI.
DR   GO; GO:0098706; P:iron ion import across cell outer membrane; IDA:MGI.
DR   GO; GO:0006826; P:iron ion transport; IMP:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:MGI.
DR   GO; GO:1902167; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:MGI.
DR   GO; GO:0009306; P:protein secretion; ISS:UniProtKB.
DR   InterPro; IPR013130; Fe3_Rdtase_TM_dom.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR028939; P5C_Rdtase_cat_N.
DR   Pfam; PF03807; F420_oxidored; 1.
DR   Pfam; PF01794; Ferric_reduct; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Cell cycle; Copper; Endosome; FAD;
KW   Flavoprotein; Glycoprotein; Heme; Ion transport; Iron; Iron transport;
KW   Membrane; Metal-binding; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..488
FT                   /note="Metalloreductase STEAP3"
FT                   /id="PRO_0000285172"
FT   TOPO_DOM        1..207
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        208..228
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        229..258
FT                   /note="Vesicular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        259..279
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        280..304
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        305..325
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        326..358
FT                   /note="Vesicular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        359..379
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        380..390
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        391..411
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        412..433
FT                   /note="Vesicular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        434..454
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        455..488
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          259..407
FT                   /note="Ferric oxidoreductase"
FT   NP_BIND         36..39
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:Q658P3"
FT   NP_BIND         58..59
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:Q658P3"
FT   NP_BIND         91..98
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:Q658P3"
FT   METAL           316
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000250|UniProtKB:Q687X5"
FT   METAL           409
FT                   /note="Iron (heme axial ligand)"
FT                   /evidence="ECO:0000250|UniProtKB:Q687X5"
FT   BINDING         116
FT                   /note="NADP; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q658P3"
FT   BINDING         151
FT                   /note="NADP; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q658P3"
FT   BINDING         152
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q687X5"
FT   BINDING         160
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q687X5"
FT   BINDING         281
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q687X5"
FT   BINDING         302
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q687X5"
FT   BINDING         378
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q687X5"
FT   BINDING         395
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q687X5"
FT   SITE            325..326
FT                   /note="Cleavage; by RHBDL4/RHBDD1"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q658P3"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19144319,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:19144319, ECO:0007744|PubMed:21183079"
FT   MOD_RES         486
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q658P3"
FT   CARBOHYD        256
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1
FT                   /note="M -> MAAEAHRQQGSCPTIPSEGCGKSPEKKGSAADSRPGTAM (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12606722"
FT                   /id="VSP_024832"
FT   MUTAGEN         316
FT                   /note="H->L: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:16227996"
FT   MUTAGEN         409
FT                   /note="H->L: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:16227996"
FT   CONFLICT        81
FT                   /note="V -> M (in Ref. 3; BAC37383)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        157
FT                   /note="G -> V (in Ref. 2; AAK50539)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        169..172
FT                   /note="SDQP -> GNQQ (in Ref. 2; AAK50539)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176..179
FT                   /note="RTIS -> QRVM (in Ref. 2; AAK50539)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212
FT                   /note="W -> G (in Ref. 2; AAK50539)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        350
FT                   /note="V -> A (in Ref. 3; BAC37383/BAE39201)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        455
FT                   /note="S -> N (in Ref. 3; BAC37383/BAE39201)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   488 AA;  54749 MW;  9A08D99C90CF83F4 CRC64;
     MSGEMDKPLI SRRLVDSDGS LAEVPKEAPK VGILGSGDFA RSLATRLVGS GFSVVVGSRN
     PKRTAGLFPS LAQVTFQEEA VSSPEVIFVA VFREHYSSLC SLADQLAGKI LVDVSNPTEK
     EHLQHRQSNA EYLASLFPAC TVVKAFNVIS AWALQAGPRD GNRQVLICSD QPEAKRTISE
     MARAMGFTPL DMGSLASARE VEAIPLRLLP SWKVPTLLAL GLFVCFYTYN FIRDVLQPYI
     RKDENKFYKM PLSVVNTTLP CVAYVLLSLV YLPGVLAAAL QLRRGTKYQR FPDWLDHWLQ
     HRKQIGLLSF FFAMLHALYS FCLPLRRSHR YDLVNLAVKQ VLANKSRLWV EEEVWRMEIY
     LSLGVLALGM LSLLAVTSLP SIANSLNWKE FSFVQSTLGF VALILSTMHT LTYGWTRAFE
     ENHYKFYLPP TFTLTLLLPC VIILAKGLFL LPCLSRRLTK IRRGWEKDGA VKFMLPGDHT
     QGEKTSHV
//
